Brain Cancer Canada is a national charity that supports people diagnosed with primary malignant brain tumours by funding research, technology and treatment.
There are over 120 different types of brain tumours, approximately one-third of them are cancerous. Brain cancers – like glioblastoma, which ended the life of Gord Downie of the Tragically Hip – are among the most fatal and insidious diseases we know. Most adults diagnosed with Glioblastoma Multiforme (GBM) survive on average 15 to 18 months after their diagnosis. Despite decades of research, malignant brain tumours are some of the deadliest forms of cancer, and remain the biggest cancer killer of adults under 40.
Brain cancer research is drastically underfunded. Despite its incredibly low survival rate, it receives less than 3% of the total funding for cancer research. With generous support from donors like you, Brain Cancer Canada is helping bridge the gap between ground-breaking research and life-saving treatments.
Brain Cancer Canada is a volunteer organization. No member receives compensation and there are no salaried employees. All net proceeds of our fundraising go directly towards research and technology. We are fully and proactively transparent about our incoming and outgoing finances, the research and technology supported, the impact they generate. Our team of board of directors, committee members, ambassadors and volunteers is comprised of highly qualified professionals with diverse skills-sets ranging from risk management, public relations, marketing, law, management, sales, and engineering.
Brain Cancer Canada is committed to facilitating the fastest possible route to managing brain cancer as a chronic disease and ultimately finding a cure.
We raise awareness and funds to enable breakthrough research and treatment options to improve the quality of life and extend the overall survival of people diagnosed with brain cancer.
There are more than 120 different types of brain tumours - approximately 30% of them are malignant.
All brain tumours can have life-altering physical, cognitive, and psychological impact on a patient’s life, however, unlike benign brain tumours, malignant tumours contain cancer cells and are considered to be life threatening because they grow quickly and invade surrounding tissue. Brain Cancer Canada needs your support to fund research, technology and treatment of malignant brain tumours. Here are some reasons why:
Brain tumours are the biggest cancer killer of adults under 40.
The average survival for the most aggressive malignant brain tumour is 15-18 months.
Brain cancer is one of the deadliest types of cancer. They remain incurable despite decades of laboratory and clinical investigation.
The last brain cancer breakthrough was in 2005 with the introduction of the chemotherapy drug temozolomide. Cancerous tumours are complex and treatment resistant. Most drugs, including many chemotherapies, cannot enter the brain to target tumours due to a protective barrier known as the “blood-brain barrier” (BBB). This means researchers and doctors are still searching to find effective treatments.
Cancerous brain tumours can rarely be completely removed during surgery due to impact on other parts of the brain and microscopic cancer cells left behind. In some cases, it may be necessary to give up some function in order to obtain a complete resection.
Brain Cancer Canada is inventing the future of brain cancer research, neurosurgical care and promising new treatments.
The entire neurosurgical team is grateful to Brain Cancer Canada for providing this state-of-the-art cranial robotic operating platform. It will have an immediate and meaningful impact on providing world-class care for all Canadians who require access to this leading technology for brain tumour surgery.
Dr. Michael Cusimano, Neurosurgeon and Scientist at St. Michael’s Hospital
Generous support from the Brain Cancer Canada is enabling research with the power to transform care for patients with brain cancer and their loved ones. Your commitment makes a statement: you understand the urgency of innovative new approaches for patients and families who can’t afford to wait. On behalf of all those who stand to benefit from better treatments for brain cancer, thank you. Your support is inventing the future of health care.
Sunnybrook, Health Sciences Centre
Invitation to apply for research grants.
Brain Cancer Canada invites Canadian researchers and institutions to apply for research grants funding for Primary Malignant Brain Tumours, with a focus on high grade gliomas (HGG). Please email firstname.lastname@example.org for a copy of proposal guidelines. Application deadline: October 8th, 2021.
For more eligibility and guidelines please download our RFP sheet.
Sponsor of Record
Scotia Wealth Management
Hampton Securities Ltd.
Yamana Gold Inc.
Concrete Forming Association of Ontario + Ontario Formwork Association
Living Realty Inc., Brokerage
Straw Construction Group
Rock Bottom Underpinning
Lipman, Zener & Waxman
Scotiabank Home Financing Solutions
Carpenters Local 27 Benefits Trust Fund (LR Trim)
Liuna Local 183
Shane Dubin, PM Canaccord Genuity
Trim Association of Ontario
F. Polsinelli Holdings
STEM Wine Group
Wyecroft Trim & Doors Group Inc.
Blu Black Group
Di Poce Management
Kilberry Hill Homes
Monon Canada Inc.
RQ Partners LLP
Wildeboer Dellelce LLP
BonGro Landscape Group
Dom D'Urzo, HFA, Scotiabank
Frank's Pizza House
Kwik Mix Materials
The Immigration Company
YORK Search Group
ASL Logistics Inc.
Bower Luxury Builds Inc.
Gene Giordano, PM, SWM
Trudel & Sons Roofing
Don’t miss the latest in medical discoveries, health tips, patient and donor impact stories, events and more from Brain Cancer Canada.
Charity No. 80359 4985 RR001
PO Box 30007 RPO Woodbine Heights
Toronto, ON M4C 5J2